The counterfeiting of medicines is a growing problem, not only in developing countries, but also in Western countries. This phenomenon can be explained by a combination of various factors such as e-commerce, the price of new medicines, and the free movement of goods.
Counterfeiters now have considerable industrial capacities, and can reproduce, in appearance at least, almost any kind of medicines from the tablet to the packaging. Producers, pharmacists, customs authorities, and patients therefore need an anti-counterfeiting technology to help recognize authentic products.
The Prooftag Solution
Thanks to its non-reproducible characteristics, the Bubble Tag™ is efficient in fighting against counterfeiting. What is more, on certain occasions, it can bring proof of authenticity even to patients.
The use of the Bubble Tag™, linked to a computerized database, makes it possible to trace every product, in order to contend with parallel markets.
The Prooftag solution enables individual identification and authentication of pharmaceutical packaging. In this way, our solution guarantees the origin and the quality of products for the entire pharmaceutical industry.
Traceability of pharmaceutical products
The unitary traceability of pharmaceutical products is a strategic approach of the pharmaceutical industry, which will become widespread in the short or medium-term. The Bubble Tag™ works in conjunction with the RFID or DataMatrix which makes such unitary traceability possible. Combined with the unitary identifier of the product, it gives a unitary proof of authenticity which can be controlled all along the supply chain.
For more than 4 years, Prooftag has been deploying unitary tracing solutions by Datamatrix in addition to the Bubble Tag™. These solutions integrate identifiers/authenticator, reading systems and manufacturing execution systems (MES), to provide ERP systems with information.
